Proceeds to advance clinical development of lead program for gout, broaden the Company’s pipeline, and expand its genomically recoded organism platform BOSTON, July 19, 2024 – GRO Biosciences Inc. (“GRObio”),…
Read More
Proceeds to advance clinical development of lead program for gout, broaden the Company’s pipeline, and expand its genomically recoded organism platform BOSTON, July 19, 2024 – GRO Biosciences Inc. (“GRObio”),…
© 2025 GRO Biosciences.